Rotllan, N, Zhang, XB, Canfran-Duque, A, Goedeke, L, Grinan, R, Ramirez, CM, Suarez, Y, Fernandez-Hernando, C. Antagonism of miR-148a attenuates atherosclerosis progression in APOB(TG )Apobec(-/-)Ldlr(+/-) mice: A brief report. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022; 153DOI:10.1016/j.biopha.2022.113419. PMID:36076541. IF:7.500(Q1/1D).

Alvarado-Tapias, E, Martí-Aguado, D, Gómez-Medina, C, Ferrero-Gregori, A, Szafranska, J, Brujats, A, Osuna-Gómez, R, Guinart-Cuadra, A, Alfaro-Cervelló, C, Pose, E, Ventura-Cots, M, Clemente, A, Fernández-Carrillo, C, Contreras, C, Cabezas, J, López-Pelayo, H, Arab, J, Argemi, J, Bataller, R. Binge drinking at time of bariatric surgery is associated with liver disease, suicides, and increases long-term mortality. Hepatology Communications. 2024; 8(8)DOI:10.1097/HC9.0000000000000490. PMID:. IF:4.600(Q1/2D).

Piedra, A, Guinart-Cuadra, A, Martínez-Recio, S, Mulet, M, Zamora, C, Osuna-Gómez, R, Cantó, E, Ortiz, MA, Alejandre, J, Barba, A, Sanz-Beltrán, J, Serra-López, J, Isla, D, Arriola, E, Paz-Ares, L, Diz-Taín, MP, Moreno, AL, Callejo, A, Vidal, S, Majem, M. Baseline PD-L1 expression on circulating immune cells as a predictor of survival and immune-related adverse events in extensive-stage small-cell lung cancer patients treated with durvalumab and carboplatin-etoposide (NCT04712903 Trial). Journal of Translational Medicine. 2026; 24(1)DOI:10.1186/s12967-026-07896-7. PMID:41764558. IF:7.500(Q1/2D).

Buddingh, Emilie Pauline, Slatter, Mary, Becerra, Juan Carlos Aldave, Garcia, Laura Alonso, von Asmuth, Erik, Baris, Safa, de la Calle-Martin, Oscar, Chan, Alice Y, Chan, Su-Wan Bianca, Chandrakasan, Shanmuganathan, Chellapandian, Deepakbabu, Dara, Jasmeen, Farmand, Susan, Fasth, Anders, Satter, Lisa Forbes, Formankova, Renata, Grunebaum, Eyal, Keogh, Steven J, Kiykim, Ayca, Kuhl, Jorn-Sven, Laberko, Alexandra, Leahy, Timothy Ronan, Lindemans, Caroline, Martinez, Caridad, Martinez-Martinez, Laura, Mitchell, William Glenn, Morris, Emma, Oved, Joseph H, Polacik, Maria, Riviere, Jacques G, Roifman, Chaim M, Kilic, Sara Sebnem, Sedlacek, Petr, Shah, Ami J, Vong, Linda, Lankester, Arjan C, Albert, Michael H, Neven, Benedicte, Torgerson, Troy, Leiding, Jennifer, Schuetz, Catharina. Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging.. Journal Of Human Immunity. 2025; 1(3)DOI:10.70962/jhi.20250027. PMID:. IF:(Q/D).